Table 1 BCP participant demographics (n = 39)
Characteristic | Frequency |
|---|---|
Median age at diagnosis | 55.5 years (range: 35 – 85) |
Cancer stage at diagnosis | |
Stage 1 | 13 (33.3%) |
Stage 2 | 21 (53.8%) |
Stage 3 | 4 (10.3%) |
Missing/unknown | 1 (2.6%) |
Cancer type | |
Invasive ductal carcinoma | 32 (82.0%) |
Other | 6 (15.4%) |
Missing/unknown | 1 ( 2.6%) |
Surgery type | |
Lumpectomy | 25 (64.1%) |
Mastectomy | 13 (33.3) |
Missing/unknown | 1 (2.6%) |
Received axillary lymph node dissection in addition to lumpectomy or mastectomy | 14 (35.9%) |
Number of patients receiving radiation therapy | 31 (79.5%) |
Therapy | |
Chemotherapy alone | 8 (20.5%) |
Chemotherapy + endocrine therapy | 21 (53.8%) |
Endocrine therapy alone | 9 (23.1%) |
Missing/unknown | 1 ( 2.6%) |
Median duration of treatment | |
(Chemotherapy and Biologic Therapy) | 156 days (range: 117–577) |
Proportion of patients receiving biologic therapy | 6 (15.4%) |